Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 9/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9203637 | 1.00 | ELANE (0.38) | ELANEPTPN1BCHEABCG2MAOB | |
| SCHEMBL7183316 | 0.95 | ELANE (0.42) | ELANEPTPN1BCHEABCG2MAOB | |
| SCHEMBL7183322 | 0.95 | ELANE (0.42) | ELANEPTPN1BCHEABCG2MAOB | |
| SCHEMBL7189192 | 0.92 | ELANE (0.45) | ELANEPTPN1BCHEABCG2 | |
| SCHEMBL7189198 | 0.92 | ELANE (0.45) | ELANEPTPN1BCHEABCG2 | |
| SCHEMBL7178715 | 0.88 | PPARG (0.40) | ELANEPTPN1BCHEABCG2 | |
| SCHEMBL7178711 | 0.88 | PPARG (0.40) | ELANEPTPN1BCHEABCG2 | |
| SCHEMBL7190380 | 0.86 | PTPN1 (0.46) | ELANEPTPN1 | |
| SCHEMBL7190378 | 0.86 | PTPN1 (0.46) | ELANEPTPN1 | |
| SCHEMBL7806429 | 0.85 | ELANE (0.39) | ELANEPTPN1BCHEABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0634927-A1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | STATENS SERUMINSTITUT (DK) | 1995-01-25 | — | — | EP | disclosed |
| WO-1993017671-A1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | STATENS SERUMINSTITUT (DK) | 1993-09-16 | — | — | WO | disclosed |